nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—SLC22A11—Methotrexate—testicular cancer	0.177	0.306	CbGbCtD
Cefazolin—ABCC4—Methotrexate—testicular cancer	0.165	0.285	CbGbCtD
Cefazolin—SLC22A8—Methotrexate—testicular cancer	0.103	0.178	CbGbCtD
Cefazolin—SLC22A6—Methotrexate—testicular cancer	0.0718	0.124	CbGbCtD
Cefazolin—ALB—Methotrexate—testicular cancer	0.0612	0.106	CbGbCtD
Cefazolin—Convulsion—Ifosfamide—testicular cancer	0.00092	0.00218	CcSEcCtD
Cefazolin—Erythema multiforme—Etoposide—testicular cancer	0.000911	0.00216	CcSEcCtD
Cefazolin—Phlebitis—Epirubicin—testicular cancer	0.000906	0.00215	CcSEcCtD
Cefazolin—Flatulence—Cisplatin—testicular cancer	0.000902	0.00214	CcSEcCtD
Cefazolin—Anorexia—Dactinomycin—testicular cancer	0.000902	0.00214	CcSEcCtD
Cefazolin—Mouth ulceration—Doxorubicin—testicular cancer	0.0009	0.00213	CcSEcCtD
Cefazolin—Diarrhoea—Chlorambucil—testicular cancer	0.000897	0.00213	CcSEcCtD
Cefazolin—Hepatic function abnormal—Epirubicin—testicular cancer	0.000893	0.00212	CcSEcCtD
Cefazolin—Hypersensitivity—Vinblastine—testicular cancer	0.000885	0.0021	CcSEcCtD
Cefazolin—Decreased appetite—Bleomycin—testicular cancer	0.000882	0.00209	CcSEcCtD
Cefazolin—Confusional state—Ifosfamide—testicular cancer	0.000874	0.00207	CcSEcCtD
Cefazolin—Hypertonia—Doxorubicin—testicular cancer	0.000872	0.00207	CcSEcCtD
Cefazolin—Pain—Bleomycin—testicular cancer	0.000867	0.00206	CcSEcCtD
Cefazolin—Anaphylactic shock—Ifosfamide—testicular cancer	0.000867	0.00206	CcSEcCtD
Cefazolin—Asthenia—Vinblastine—testicular cancer	0.000862	0.00204	CcSEcCtD
Cefazolin—Thrombocytopenia—Ifosfamide—testicular cancer	0.000849	0.00201	CcSEcCtD
Cefazolin—Anaemia—Cisplatin—testicular cancer	0.000846	0.00201	CcSEcCtD
Cefazolin—Phlebitis—Doxorubicin—testicular cancer	0.000839	0.00199	CcSEcCtD
Cefazolin—Feeling abnormal—Bleomycin—testicular cancer	0.000836	0.00198	CcSEcCtD
Cefazolin—Vomiting—Chlorambucil—testicular cancer	0.000833	0.00198	CcSEcCtD
Cefazolin—Hepatic function abnormal—Doxorubicin—testicular cancer	0.000827	0.00196	CcSEcCtD
Cefazolin—Anorexia—Ifosfamide—testicular cancer	0.000826	0.00196	CcSEcCtD
Cefazolin—Decreased appetite—Dactinomycin—testicular cancer	0.000822	0.00195	CcSEcCtD
Cefazolin—Diarrhoea—Vinblastine—testicular cancer	0.000822	0.00195	CcSEcCtD
Cefazolin—Leukopenia—Cisplatin—testicular cancer	0.00082	0.00194	CcSEcCtD
Cefazolin—Fatigue—Dactinomycin—testicular cancer	0.000816	0.00193	CcSEcCtD
Cefazolin—Hypotension—Ifosfamide—testicular cancer	0.00081	0.00192	CcSEcCtD
Cefazolin—Pain—Dactinomycin—testicular cancer	0.000809	0.00192	CcSEcCtD
Cefazolin—Urticaria—Bleomycin—testicular cancer	0.000806	0.00191	CcSEcCtD
Cefazolin—Body temperature increased—Bleomycin—testicular cancer	0.000802	0.0019	CcSEcCtD
Cefazolin—Dizziness—Vinblastine—testicular cancer	0.000794	0.00188	CcSEcCtD
Cefazolin—Convulsion—Cisplatin—testicular cancer	0.000793	0.00188	CcSEcCtD
Cefazolin—Feeling abnormal—Dactinomycin—testicular cancer	0.00078	0.00185	CcSEcCtD
Cefazolin—Nausea—Chlorambucil—testicular cancer	0.000778	0.00185	CcSEcCtD
Cefazolin—Anaemia—Etoposide—testicular cancer	0.000775	0.00184	CcSEcCtD
Cefazolin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000774	0.00183	CcSEcCtD
Cefazolin—Somnolence—Ifosfamide—testicular cancer	0.000771	0.00183	CcSEcCtD
Cefazolin—Vomiting—Vinblastine—testicular cancer	0.000764	0.00181	CcSEcCtD
Cefazolin—Decreased appetite—Ifosfamide—testicular cancer	0.000754	0.00179	CcSEcCtD
Cefazolin—Headache—Vinblastine—testicular cancer	0.000752	0.00178	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000751	0.00178	CcSEcCtD
Cefazolin—Leukopenia—Etoposide—testicular cancer	0.000751	0.00178	CcSEcCtD
Cefazolin—Body temperature increased—Dactinomycin—testicular cancer	0.000748	0.00177	CcSEcCtD
Cefazolin—Abdominal pain—Dactinomycin—testicular cancer	0.000748	0.00177	CcSEcCtD
Cefazolin—Fatigue—Ifosfamide—testicular cancer	0.000747	0.00177	CcSEcCtD
Cefazolin—Anaphylactic shock—Cisplatin—testicular cancer	0.000747	0.00177	CcSEcCtD
Cefazolin—Hypersensitivity—Bleomycin—testicular cancer	0.000747	0.00177	CcSEcCtD
Cefazolin—Pain—Ifosfamide—testicular cancer	0.000741	0.00176	CcSEcCtD
Cefazolin—Loss of consciousness—Etoposide—testicular cancer	0.000737	0.00175	CcSEcCtD
Cefazolin—Thrombocytopenia—Cisplatin—testicular cancer	0.000732	0.00174	CcSEcCtD
Cefazolin—Blood creatinine increased—Epirubicin—testicular cancer	0.000731	0.00174	CcSEcCtD
Cefazolin—Asthenia—Bleomycin—testicular cancer	0.000728	0.00173	CcSEcCtD
Cefazolin—Convulsion—Etoposide—testicular cancer	0.000727	0.00172	CcSEcCtD
Cefazolin—Pruritus—Bleomycin—testicular cancer	0.000718	0.0017	CcSEcCtD
Cefazolin—Feeling abnormal—Ifosfamide—testicular cancer	0.000714	0.00169	CcSEcCtD
Cefazolin—Eosinophilia—Methotrexate—testicular cancer	0.000714	0.00169	CcSEcCtD
Cefazolin—Nausea—Vinblastine—testicular cancer	0.000713	0.00169	CcSEcCtD
Cefazolin—Abdominal pain upper—Epirubicin—testicular cancer	0.000713	0.00169	CcSEcCtD
Cefazolin—Anorexia—Cisplatin—testicular cancer	0.000712	0.00169	CcSEcCtD
Cefazolin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000709	0.00168	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000703	0.00167	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.000703	0.00167	CcSEcCtD
Cefazolin—Hypotension—Cisplatin—testicular cancer	0.000698	0.00166	CcSEcCtD
Cefazolin—Hypersensitivity—Dactinomycin—testicular cancer	0.000697	0.00165	CcSEcCtD
Cefazolin—Confusional state—Etoposide—testicular cancer	0.00069	0.00164	CcSEcCtD
Cefazolin—Urticaria—Ifosfamide—testicular cancer	0.000689	0.00163	CcSEcCtD
Cefazolin—Abdominal pain—Ifosfamide—testicular cancer	0.000685	0.00163	CcSEcCtD
Cefazolin—Body temperature increased—Ifosfamide—testicular cancer	0.000685	0.00163	CcSEcCtD
Cefazolin—Pancytopenia—Methotrexate—testicular cancer	0.000685	0.00162	CcSEcCtD
Cefazolin—Anaphylactic shock—Etoposide—testicular cancer	0.000685	0.00162	CcSEcCtD
Cefazolin—Asthenia—Dactinomycin—testicular cancer	0.000679	0.00161	CcSEcCtD
Cefazolin—Blood creatinine increased—Doxorubicin—testicular cancer	0.000677	0.00161	CcSEcCtD
Cefazolin—Neutropenia—Methotrexate—testicular cancer	0.000674	0.0016	CcSEcCtD
Cefazolin—Thrombocytopenia—Etoposide—testicular cancer	0.00067	0.00159	CcSEcCtD
Cefazolin—Eosinophilia—Epirubicin—testicular cancer	0.000668	0.00159	CcSEcCtD
Cefazolin—Abdominal pain upper—Doxorubicin—testicular cancer	0.00066	0.00157	CcSEcCtD
Cefazolin—Anorexia—Etoposide—testicular cancer	0.000653	0.00155	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000651	0.00154	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000651	0.00154	CcSEcCtD
Cefazolin—Decreased appetite—Cisplatin—testicular cancer	0.00065	0.00154	CcSEcCtD
Cefazolin—Diarrhoea—Dactinomycin—testicular cancer	0.000647	0.00154	CcSEcCtD
Cefazolin—Vomiting—Bleomycin—testicular cancer	0.000645	0.00153	CcSEcCtD
Cefazolin—Pancytopenia—Epirubicin—testicular cancer	0.000641	0.00152	CcSEcCtD
Cefazolin—Hypotension—Etoposide—testicular cancer	0.00064	0.00152	CcSEcCtD
Cefazolin—Rash—Bleomycin—testicular cancer	0.00064	0.00152	CcSEcCtD
Cefazolin—Pain—Cisplatin—testicular cancer	0.000639	0.00152	CcSEcCtD
Cefazolin—Dermatitis—Bleomycin—testicular cancer	0.000639	0.00152	CcSEcCtD
Cefazolin—Hypersensitivity—Ifosfamide—testicular cancer	0.000639	0.00151	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000637	0.00151	CcSEcCtD
Cefazolin—Renal failure—Methotrexate—testicular cancer	0.000632	0.0015	CcSEcCtD
Cefazolin—Neutropenia—Epirubicin—testicular cancer	0.000631	0.0015	CcSEcCtD
Cefazolin—Stomatitis—Methotrexate—testicular cancer	0.000627	0.00149	CcSEcCtD
Cefazolin—Asthenia—Ifosfamide—testicular cancer	0.000622	0.00148	CcSEcCtD
Cefazolin—Eosinophilia—Doxorubicin—testicular cancer	0.000618	0.00147	CcSEcCtD
Cefazolin—Feeling abnormal—Cisplatin—testicular cancer	0.000616	0.00146	CcSEcCtD
Cefazolin—Pruritus—Ifosfamide—testicular cancer	0.000613	0.00145	CcSEcCtD
Cefazolin—Somnolence—Etoposide—testicular cancer	0.000609	0.00144	CcSEcCtD
Cefazolin—Nausea—Bleomycin—testicular cancer	0.000602	0.00143	CcSEcCtD
Cefazolin—Vomiting—Dactinomycin—testicular cancer	0.000601	0.00143	CcSEcCtD
Cefazolin—Agranulocytosis—Methotrexate—testicular cancer	0.0006	0.00142	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000597	0.00142	CcSEcCtD
Cefazolin—Rash—Dactinomycin—testicular cancer	0.000596	0.00141	CcSEcCtD
Cefazolin—Decreased appetite—Etoposide—testicular cancer	0.000595	0.00141	CcSEcCtD
Cefazolin—Diarrhoea—Ifosfamide—testicular cancer	0.000593	0.00141	CcSEcCtD
Cefazolin—Pancytopenia—Doxorubicin—testicular cancer	0.000593	0.00141	CcSEcCtD
Cefazolin—Renal failure—Epirubicin—testicular cancer	0.000591	0.0014	CcSEcCtD
Cefazolin—Body temperature increased—Cisplatin—testicular cancer	0.000591	0.0014	CcSEcCtD
Cefazolin—Fatigue—Etoposide—testicular cancer	0.00059	0.0014	CcSEcCtD
Cefazolin—Stomatitis—Epirubicin—testicular cancer	0.000587	0.00139	CcSEcCtD
Cefazolin—Pain—Etoposide—testicular cancer	0.000585	0.00139	CcSEcCtD
Cefazolin—Neutropenia—Doxorubicin—testicular cancer	0.000584	0.00139	CcSEcCtD
Cefazolin—Haemoglobin—Methotrexate—testicular cancer	0.00058	0.00138	CcSEcCtD
Cefazolin—Haemorrhage—Methotrexate—testicular cancer	0.000577	0.00137	CcSEcCtD
Cefazolin—Hepatitis—Methotrexate—testicular cancer	0.000577	0.00137	CcSEcCtD
Cefazolin—Dizziness—Ifosfamide—testicular cancer	0.000573	0.00136	CcSEcCtD
Cefazolin—Feeling abnormal—Etoposide—testicular cancer	0.000564	0.00134	CcSEcCtD
Cefazolin—Nausea—Dactinomycin—testicular cancer	0.000562	0.00133	CcSEcCtD
Cefazolin—Agranulocytosis—Epirubicin—testicular cancer	0.000562	0.00133	CcSEcCtD
Cefazolin—Gastrointestinal pain—Etoposide—testicular cancer	0.00056	0.00133	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000552	0.00131	CcSEcCtD
Cefazolin—Vomiting—Ifosfamide—testicular cancer	0.000551	0.00131	CcSEcCtD
Cefazolin—Hypersensitivity—Cisplatin—testicular cancer	0.000551	0.00131	CcSEcCtD
Cefazolin—Renal failure—Doxorubicin—testicular cancer	0.000547	0.0013	CcSEcCtD
Cefazolin—Rash—Ifosfamide—testicular cancer	0.000547	0.0013	CcSEcCtD
Cefazolin—Dermatitis—Ifosfamide—testicular cancer	0.000546	0.0013	CcSEcCtD
Cefazolin—Erythema multiforme—Methotrexate—testicular cancer	0.000546	0.00129	CcSEcCtD
Cefazolin—Urticaria—Etoposide—testicular cancer	0.000544	0.00129	CcSEcCtD
Cefazolin—Haemoglobin—Epirubicin—testicular cancer	0.000543	0.00129	CcSEcCtD
Cefazolin—Stomatitis—Doxorubicin—testicular cancer	0.000543	0.00129	CcSEcCtD
Cefazolin—Abdominal pain—Etoposide—testicular cancer	0.000541	0.00128	CcSEcCtD
Cefazolin—Body temperature increased—Etoposide—testicular cancer	0.000541	0.00128	CcSEcCtD
Cefazolin—Haemorrhage—Epirubicin—testicular cancer	0.00054	0.00128	CcSEcCtD
Cefazolin—Hepatitis—Epirubicin—testicular cancer	0.00054	0.00128	CcSEcCtD
Cefazolin—Asthenia—Cisplatin—testicular cancer	0.000536	0.00127	CcSEcCtD
Cefazolin—Agranulocytosis—Doxorubicin—testicular cancer	0.00052	0.00123	CcSEcCtD
Cefazolin—Nausea—Ifosfamide—testicular cancer	0.000515	0.00122	CcSEcCtD
Cefazolin—Diarrhoea—Cisplatin—testicular cancer	0.000511	0.00121	CcSEcCtD
Cefazolin—Erythema multiforme—Epirubicin—testicular cancer	0.000511	0.00121	CcSEcCtD
Cefazolin—Hypersensitivity—Etoposide—testicular cancer	0.000504	0.0012	CcSEcCtD
Cefazolin—Haemoglobin—Doxorubicin—testicular cancer	0.000502	0.00119	CcSEcCtD
Cefazolin—Haemorrhage—Doxorubicin—testicular cancer	0.0005	0.00119	CcSEcCtD
Cefazolin—Hepatitis—Doxorubicin—testicular cancer	0.0005	0.00119	CcSEcCtD
Cefazolin—Asthenia—Etoposide—testicular cancer	0.000491	0.00117	CcSEcCtD
Cefazolin—Pruritus—Etoposide—testicular cancer	0.000484	0.00115	CcSEcCtD
Cefazolin—Vomiting—Cisplatin—testicular cancer	0.000475	0.00113	CcSEcCtD
Cefazolin—Erythema multiforme—Doxorubicin—testicular cancer	0.000473	0.00112	CcSEcCtD
Cefazolin—Rash—Cisplatin—testicular cancer	0.000471	0.00112	CcSEcCtD
Cefazolin—Dermatitis—Cisplatin—testicular cancer	0.000471	0.00112	CcSEcCtD
Cefazolin—Diarrhoea—Etoposide—testicular cancer	0.000468	0.00111	CcSEcCtD
Cefazolin—Anaemia—Methotrexate—testicular cancer	0.000464	0.0011	CcSEcCtD
Cefazolin—Flatulence—Epirubicin—testicular cancer	0.000463	0.0011	CcSEcCtD
Cefazolin—Dizziness—Etoposide—testicular cancer	0.000453	0.00107	CcSEcCtD
Cefazolin—Leukopenia—Methotrexate—testicular cancer	0.00045	0.00107	CcSEcCtD
Cefazolin—Nausea—Cisplatin—testicular cancer	0.000444	0.00105	CcSEcCtD
Cefazolin—Convulsion—Methotrexate—testicular cancer	0.000435	0.00103	CcSEcCtD
Cefazolin—Vomiting—Etoposide—testicular cancer	0.000435	0.00103	CcSEcCtD
Cefazolin—Anaemia—Epirubicin—testicular cancer	0.000435	0.00103	CcSEcCtD
Cefazolin—Agitation—Epirubicin—testicular cancer	0.000432	0.00103	CcSEcCtD
Cefazolin—Rash—Etoposide—testicular cancer	0.000432	0.00102	CcSEcCtD
Cefazolin—Dermatitis—Etoposide—testicular cancer	0.000431	0.00102	CcSEcCtD
Cefazolin—Headache—Etoposide—testicular cancer	0.000429	0.00102	CcSEcCtD
Cefazolin—Flatulence—Doxorubicin—testicular cancer	0.000429	0.00102	CcSEcCtD
Cefazolin—Syncope—Epirubicin—testicular cancer	0.000422	0.001	CcSEcCtD
Cefazolin—Leukopenia—Epirubicin—testicular cancer	0.000421	0.000998	CcSEcCtD
Cefazolin—Confusional state—Methotrexate—testicular cancer	0.000413	0.000981	CcSEcCtD
Cefazolin—Loss of consciousness—Epirubicin—testicular cancer	0.000413	0.00098	CcSEcCtD
Cefazolin—Anaphylactic shock—Methotrexate—testicular cancer	0.00041	0.000973	CcSEcCtD
Cefazolin—Convulsion—Epirubicin—testicular cancer	0.000407	0.000966	CcSEcCtD
Cefazolin—Nausea—Etoposide—testicular cancer	0.000407	0.000965	CcSEcCtD
Cefazolin—Anaemia—Doxorubicin—testicular cancer	0.000402	0.000954	CcSEcCtD
Cefazolin—Thrombocytopenia—Methotrexate—testicular cancer	0.000402	0.000952	CcSEcCtD
Cefazolin—Agitation—Doxorubicin—testicular cancer	0.0004	0.000948	CcSEcCtD
Cefazolin—Anorexia—Methotrexate—testicular cancer	0.000391	0.000927	CcSEcCtD
Cefazolin—Syncope—Doxorubicin—testicular cancer	0.00039	0.000926	CcSEcCtD
Cefazolin—Leukopenia—Doxorubicin—testicular cancer	0.000389	0.000924	CcSEcCtD
Cefazolin—Confusional state—Epirubicin—testicular cancer	0.000387	0.000918	CcSEcCtD
Cefazolin—Anaphylactic shock—Epirubicin—testicular cancer	0.000384	0.00091	CcSEcCtD
Cefazolin—Hypotension—Methotrexate—testicular cancer	0.000383	0.000909	CcSEcCtD
Cefazolin—Loss of consciousness—Doxorubicin—testicular cancer	0.000382	0.000907	CcSEcCtD
Cefazolin—Shock—Epirubicin—testicular cancer	0.000378	0.000896	CcSEcCtD
Cefazolin—Convulsion—Doxorubicin—testicular cancer	0.000377	0.000894	CcSEcCtD
Cefazolin—Thrombocytopenia—Epirubicin—testicular cancer	0.000376	0.000891	CcSEcCtD
Cefazolin—Anorexia—Epirubicin—testicular cancer	0.000366	0.000868	CcSEcCtD
Cefazolin—Somnolence—Methotrexate—testicular cancer	0.000365	0.000865	CcSEcCtD
Cefazolin—Dyspepsia—Methotrexate—testicular cancer	0.000361	0.000856	CcSEcCtD
Cefazolin—Hypotension—Epirubicin—testicular cancer	0.000359	0.000851	CcSEcCtD
Cefazolin—Confusional state—Doxorubicin—testicular cancer	0.000358	0.000849	CcSEcCtD
Cefazolin—Decreased appetite—Methotrexate—testicular cancer	0.000356	0.000846	CcSEcCtD
Cefazolin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000355	0.000842	CcSEcCtD
Cefazolin—Fatigue—Methotrexate—testicular cancer	0.000354	0.000839	CcSEcCtD
Cefazolin—Pain—Methotrexate—testicular cancer	0.000351	0.000832	CcSEcCtD
Cefazolin—Shock—Doxorubicin—testicular cancer	0.000349	0.000829	CcSEcCtD
Cefazolin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000348	0.000825	CcSEcCtD
Cefazolin—Somnolence—Epirubicin—testicular cancer	0.000341	0.000809	CcSEcCtD
Cefazolin—Anorexia—Doxorubicin—testicular cancer	0.000338	0.000803	CcSEcCtD
Cefazolin—Feeling abnormal—Methotrexate—testicular cancer	0.000338	0.000802	CcSEcCtD
Cefazolin—Dyspepsia—Epirubicin—testicular cancer	0.000338	0.000801	CcSEcCtD
Cefazolin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000335	0.000795	CcSEcCtD
Cefazolin—Decreased appetite—Epirubicin—testicular cancer	0.000334	0.000791	CcSEcCtD
Cefazolin—Hypotension—Doxorubicin—testicular cancer	0.000332	0.000787	CcSEcCtD
Cefazolin—Fatigue—Epirubicin—testicular cancer	0.000331	0.000785	CcSEcCtD
Cefazolin—Pain—Epirubicin—testicular cancer	0.000328	0.000778	CcSEcCtD
Cefazolin—Urticaria—Methotrexate—testicular cancer	0.000326	0.000773	CcSEcCtD
Cefazolin—Abdominal pain—Methotrexate—testicular cancer	0.000324	0.000769	CcSEcCtD
Cefazolin—Body temperature increased—Methotrexate—testicular cancer	0.000324	0.000769	CcSEcCtD
Cefazolin—Feeling abnormal—Epirubicin—testicular cancer	0.000316	0.00075	CcSEcCtD
Cefazolin—Somnolence—Doxorubicin—testicular cancer	0.000316	0.000749	CcSEcCtD
Cefazolin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000314	0.000744	CcSEcCtD
Cefazolin—Dyspepsia—Doxorubicin—testicular cancer	0.000313	0.000741	CcSEcCtD
Cefazolin—Decreased appetite—Doxorubicin—testicular cancer	0.000309	0.000732	CcSEcCtD
Cefazolin—Fatigue—Doxorubicin—testicular cancer	0.000306	0.000726	CcSEcCtD
Cefazolin—Urticaria—Epirubicin—testicular cancer	0.000305	0.000723	CcSEcCtD
Cefazolin—Pain—Doxorubicin—testicular cancer	0.000304	0.00072	CcSEcCtD
Cefazolin—Abdominal pain—Epirubicin—testicular cancer	0.000303	0.00072	CcSEcCtD
Cefazolin—Body temperature increased—Epirubicin—testicular cancer	0.000303	0.00072	CcSEcCtD
Cefazolin—Hypersensitivity—Methotrexate—testicular cancer	0.000302	0.000717	CcSEcCtD
Cefazolin—Asthenia—Methotrexate—testicular cancer	0.000294	0.000698	CcSEcCtD
Cefazolin—Feeling abnormal—Doxorubicin—testicular cancer	0.000293	0.000694	CcSEcCtD
Cefazolin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00029	0.000689	CcSEcCtD
Cefazolin—Pruritus—Methotrexate—testicular cancer	0.00029	0.000688	CcSEcCtD
Cefazolin—Hypersensitivity—Epirubicin—testicular cancer	0.000283	0.000671	CcSEcCtD
Cefazolin—Urticaria—Doxorubicin—testicular cancer	0.000282	0.000669	CcSEcCtD
Cefazolin—Abdominal pain—Doxorubicin—testicular cancer	0.000281	0.000666	CcSEcCtD
Cefazolin—Body temperature increased—Doxorubicin—testicular cancer	0.000281	0.000666	CcSEcCtD
Cefazolin—Diarrhoea—Methotrexate—testicular cancer	0.000281	0.000666	CcSEcCtD
Cefazolin—Asthenia—Epirubicin—testicular cancer	0.000275	0.000653	CcSEcCtD
Cefazolin—Pruritus—Epirubicin—testicular cancer	0.000272	0.000644	CcSEcCtD
Cefazolin—Dizziness—Methotrexate—testicular cancer	0.000271	0.000643	CcSEcCtD
Cefazolin—Diarrhoea—Epirubicin—testicular cancer	0.000263	0.000623	CcSEcCtD
Cefazolin—Hypersensitivity—Doxorubicin—testicular cancer	0.000262	0.000621	CcSEcCtD
Cefazolin—Vomiting—Methotrexate—testicular cancer	0.000261	0.000619	CcSEcCtD
Cefazolin—Rash—Methotrexate—testicular cancer	0.000259	0.000613	CcSEcCtD
Cefazolin—Dermatitis—Methotrexate—testicular cancer	0.000258	0.000613	CcSEcCtD
Cefazolin—Headache—Methotrexate—testicular cancer	0.000257	0.000609	CcSEcCtD
Cefazolin—Asthenia—Doxorubicin—testicular cancer	0.000255	0.000604	CcSEcCtD
Cefazolin—Dizziness—Epirubicin—testicular cancer	0.000254	0.000602	CcSEcCtD
Cefazolin—Pruritus—Doxorubicin—testicular cancer	0.000251	0.000596	CcSEcCtD
Cefazolin—Vomiting—Epirubicin—testicular cancer	0.000244	0.000579	CcSEcCtD
Cefazolin—Nausea—Methotrexate—testicular cancer	0.000244	0.000578	CcSEcCtD
Cefazolin—Diarrhoea—Doxorubicin—testicular cancer	0.000243	0.000576	CcSEcCtD
Cefazolin—Rash—Epirubicin—testicular cancer	0.000242	0.000574	CcSEcCtD
Cefazolin—Dermatitis—Epirubicin—testicular cancer	0.000242	0.000573	CcSEcCtD
Cefazolin—Headache—Epirubicin—testicular cancer	0.00024	0.00057	CcSEcCtD
Cefazolin—Dizziness—Doxorubicin—testicular cancer	0.000235	0.000557	CcSEcCtD
Cefazolin—Nausea—Epirubicin—testicular cancer	0.000228	0.000541	CcSEcCtD
Cefazolin—Vomiting—Doxorubicin—testicular cancer	0.000226	0.000536	CcSEcCtD
Cefazolin—Rash—Doxorubicin—testicular cancer	0.000224	0.000531	CcSEcCtD
Cefazolin—Dermatitis—Doxorubicin—testicular cancer	0.000224	0.000531	CcSEcCtD
Cefazolin—Headache—Doxorubicin—testicular cancer	0.000222	0.000528	CcSEcCtD
Cefazolin—Nausea—Doxorubicin—testicular cancer	0.000211	0.0005	CcSEcCtD
